Papular mycosis fungoides: A variant of mycosis fungoides or lymphomatoid papulosis?

Journal of the American Academy of Dermatology

Volumn 55, Issue 1, 2006, Pages 177-180

  Vonderheid, Eric C ^a   Kadin, Marshall E ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LARGE CELL LYMPHOMA; LETTER; LYMPHOCYTE; LYMPHOMA; LYMPHOMATOID PAPULOSIS; MOLECULAR GENETICS; MYCOSIS FUNGOIDES; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN BIOPSY; SKIN MANIFESTATION; T LYMPHOCYTE;

DIAGNOSIS, DIFFERENTIAL; HUMANS; LYMPHOMATOID PAPULOSIS; MYCOSIS FUNGOIDES; SKIN NEOPLASMS;

EID: 33745001243     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.01.030     Document Type: Letter

References (22)

1. Kodama K., Fink-Puches R., Massone C., Kerl H., and Cerroni L. Papular mycosis fungoides: a new clinical variant of early mycosis fungoides. J Am Acad Dermatol 52 (2005) 694-698
2. El Shabrawi-Caelen L., Kerl H., and Cerroni L. Lymphomatoid papulosis: reappraisal of clinicopathologic presentation and classification into subtypes A, B, and C. Arch Dermatol 140 (2004) 441-447
3. Wu H., Telang G., Lessin S.R., and Vonderheid E.C. Mycosis fungoides with CD30-positive cells in the epidermis. J Dermatopathol 22 (2000) 212-216
4. Ackerman A.B., Niven J., and Grant-Kels J.M. Lymphomatoid papulosis vs. mycosis fungoides, plaque stage. In: Ackerman A.B., Niven J., and Grant-Kels J.M. (Eds). Differential Diagnosis in Dermatopathology (1982), Lea and Febiger, Philadelphia 158-165
5. Bekkenk M.W., Geelen F.A.M.J., van Voorst Vader P.C., Heule F., Geerts M.-L., van Vloten W.A., et al. Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment. Blood 95 (2000) 3653-3661
6. Zackheim H.S., Jones C., LeBoit P.E., Kashani-Sabet M., McCalmont T.H., and Zehnder J. Lymphomatoid papulosis associated with mycosis fungoides: a study of 21 patients including analyses for clonality. J Am Acad Dermatol 49 (2003) 620-623
7. Vonderheid E.C., Bernengo M.G., Burg G., Duvic M., Heald P., Laroche L., et al. Update on erythrodermic cutaneous T-cell lymphoma: Report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 46 (2002) 95-106
8. Burg G., Dummer R., Haeffner A., Kempf W., and Kadin M. From inflammation to neoplasia: mycosis fungoides evolves from reactive inflammatory conditions (lymphoid infiltrates) transforming into neoplastic plaques and tumors. Arch Dermatol 137 (2001) 949-952
9. Willemze R., Jaffe E.S., Burg G., Cerroni L., Berti E., Swerdlow S.H., et al. WHO-EORTC classification for cutaneous lymphomas. Blood 105 (2005) 3768-3785
10. Chott A., Vonderheid E.C., Olbricht S., Miao N.N., Balk S.P., and Kadin M.E. The same dominant T cell clone is present in multiple regressing skin lesions and associated T cell lymphomas of patients with lymphomatoid papulosis. J Invest Dermatol 106 (1996) 696-700
11. Basarab T., Fraser-Andrews E.A., Orchard G., Whittaker S., and Russell-Jones R. Lymphomatoid papulosis in association with mycosis fungoides: a study of 15 cases. Br J Dermatol 139 (1998) 630-638
12. Gallardo F., Costa C., Bellosillo B., Solé F., Estrach T., Servitje O., et al. Lymphomatoid papulosis associated with mycosis fungoides: clinicopathological and molecular studies of 12 cases. Acta Derm Venereol 84 (2004) 463-468
13. Whittaker S.J., Smith N.P., Russell-Jones R., and Luzzatto L. Analysis of β, γ, and δ T-cell receptor genes in Lymphomatoid papulosis: cellular basis of two distinct histologic subsets. J Invest Dermatol 96 (1991) 786-791
14. Gellrich S., Wernicke M., Wilks A., Lukowsky A., Muche J.M., Jasch K.C., et al. The cell infiltrate in lymphomatoid papulosis comprises a mixture of polyclonal large atypical cells (CD30-positive) and smaller monoclonal T cells (CD30-negative). J Invest Dermatol 122 (2004) 859-861
15. Steinhoff M., Hummel M., Anagnostopoulos I., Kaudewitz P., Seitz V., Assaf C., et al. Single-cell analysis of CD30+ cells in lymphomatoid papulosis demonstrates a common clonal T-cell origin. Blood 100 (2002) 578-584
16. Knaus P.I., Lindermann D., DeCoteau J.F., Perlman R., Yankelev H., Hille M., et al. A dominant inhibitory mutant of the type II transforming growth factor β receptor in the malignant progression of a cutaneous T-cell lymphoma. Mol Cell Biol 16 (1996) 3480-3489
17. Schiemann W.P., Pfeifer W.M., Levi E., Kadin M.E., and Lodish H.F. A deletion in the gene for transforming growth factor beta type I receptor abolishes growth regulation by transforming growth factor beta in a cutaneous T-cell lymphoma. Blood 94 (1999) 2854-2861
18. Rübben A., Kempf W., Kadin M.E., Dieter R., Zimmermann D.R., and Burg G. Multilineage progression of genetically unstable tumor subclones in cutaneous T-cell lymphoma. Exp Dermatol 13 (2004) 472-483
19. Davis T.H., Morton C.C., Miller-Cassman R., Balk S.P., and Kadin M.E. Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone. N Engl J Med 326 (1992) 1115-1122
20. Veelken H., Sklar J.L., and Wood G.S. Detection of low-level tumor cells in allergic contact dermatitis induced by mechlorethamine in patients with mycosis fungoides. J Invest Dermatol 106 (1996) 685-688
21. Agnarsson B.A., and Kadin M.E. Host Response in lymphomatoid papulosis. Hum Pathol 20 (1989) 747-752
22. Kadin M.E., Levi E., and Kempf W. Progression of lymphomatoid papulosis to systemic lymphoma is associated with escape from growth inhibition by transforming growth factor-beta and CD30 ligand. Ann N Y Acad Sci 941 (2001) 59-68